These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
262 related articles for article (PubMed ID: 30019395)
1. Family dynamics in transthyretin-related familial amyloid polyneuropathy Val30Met: Does genetic risk affect family functioning? Lopes A; Rodrigues C; Fonseca I; Sousa A; Branco M; Coelho T; Sequeiros J; Freitas P Clin Genet; 2018 Nov; 94(5):401-408. PubMed ID: 30019395 [TBL] [Abstract][Full Text] [Related]
2. Late-onset familial amyloid polyneuropathy (FAP) Val30Met without family history. Rudolph T; Kurz MW; Farbu E Clin Med Res; 2008 Sep; 6(2):80-2. PubMed ID: 18606975 [TBL] [Abstract][Full Text] [Related]
3. Coexistence of familial transthyretin amyloidosis ATTR Val30Met and spinocerebellar ataxia type 1 in a Japanese family--a follow-up autopsy report. Oide T; Arima K; Yamazaki M; Hanyu N; Ikeda S Amyloid; 2004 Sep; 11(3):191-9. PubMed ID: 15523922 [TBL] [Abstract][Full Text] [Related]
4. Genotypic and phenotypic presentation of transthyretin-related familial amyloid polyneuropathy (TTR-FAP) in Turkey. Durmuş-Tekçe H; Matur Z; Mert Atmaca M; Poda M; Çakar A; Hıdır Ulaş Ü; Oflazer-Serdaroğlu P; Deymeer F; Parman YG Neuromuscul Disord; 2016 Jul; 26(7):441-6. PubMed ID: 27238058 [TBL] [Abstract][Full Text] [Related]
5. Transthyretin-related familial amyloid polyneuropathy (ATTR-FAP) in Poland - genetic and clinical presentation. Lipowska M; Drac H; Rowczenio D; Gilbertson J; Hawkins PN; Lasek-Bal A; Szewczuk J; Grzybowski J; Gawor M; Stępień-Wojno M; Franaszczyk M; Brydak-Godowska J; Śmierciak R; Ptasińska-Perkowska A; Chandoga J; Petrovic R; Kostera-Pruszczyk A Neurol Neurochir Pol; 2020; 54(6):552-560. PubMed ID: 33373035 [TBL] [Abstract][Full Text] [Related]
6. Late-onset Transthyretin (TTR)-familial Amyloid Polyneuropathy (FAP) with a Long Disease Duration from Non-endemic Areas in Japan. Miyake Z; Nakamagoe K; Ezawa N; Yoshinaga T; Hashimoto R; Sato T; Sekijima Y; Tamaoka A Intern Med; 2019 Mar; 58(5):713-718. PubMed ID: 30333406 [TBL] [Abstract][Full Text] [Related]
7. Origin of sporadic late-onset hereditary ATTR Val30Met amyloidosis in Japan. Ueda M; Yamashita T; Misumi Y; Masuda T; Ando Y Amyloid; 2018 Sep; 25(3):143-147. PubMed ID: 30486687 [TBL] [Abstract][Full Text] [Related]
8. Diagnosis of sporadic transthyretin Val30Met familial amyloid polyneuropathy: a practical analysis. Koike H; Hashimoto R; Tomita M; Kawagashira Y; Iijima M; Tanaka F; Sobue G Amyloid; 2011 Jun; 18(2):53-62. PubMed ID: 21463231 [TBL] [Abstract][Full Text] [Related]
9. Upper limb neuropathy such as carpal tunnel syndrome as an initial manifestation of ATTR Val30Met familial amyloid polyneuropathy. Tojo K; Tsuchiya-Suzuki A; Sekijima Y; Morita H; Sumita N; Ikeda S Amyloid; 2010 Mar; 17(1):32-5. PubMed ID: 20132088 [TBL] [Abstract][Full Text] [Related]
10. Effects of tafamidis treatment on transthyretin (TTR) stabilization, efficacy, and safety in Japanese patients with familial amyloid polyneuropathy (TTR-FAP) with Val30Met and non-Val30Met: A phase III, open-label study. Ando Y; Sekijima Y; Obayashi K; Yamashita T; Ueda M; Misumi Y; Morita H; Machii K; Ohta M; Takata A; Ikeda S J Neurol Sci; 2016 Mar; 362():266-71. PubMed ID: 26944161 [TBL] [Abstract][Full Text] [Related]
11. Clinical and pathological studies of cardiac amyloidosis in transthyretin type familial amyloid polyneuropathy. Hattori T; Takei Y; Koyama J; Nakazato M; Ikeda S Amyloid; 2003 Dec; 10(4):229-39. PubMed ID: 14986482 [TBL] [Abstract][Full Text] [Related]
13. Effect of albumin on transthyretin and amyloidogenic transthyretin Val30Met disposition and tissue deposition in familial amyloidotic polyneuropathy. Taguchi K; Jono H; Kugimiya-Taguchi T; Nagao S; Su Y; Yamasaki K; Mizuguchi M; Maruyama T; Ando Y; Otagiri M Life Sci; 2013 Dec; 93(25-26):1017-22. PubMed ID: 24211615 [TBL] [Abstract][Full Text] [Related]
14. Large normal alleles of ATXN2 decrease age at onset in transthyretin familial amyloid polyneuropathy Val30Met patients. Santos D; Coelho T; Alves-Ferreira M; Sequeiros J; Mendonça D; Alonso I; Sousa A; Lemos C Ann Neurol; 2019 Feb; 85(2):251-258. PubMed ID: 30615214 [TBL] [Abstract][Full Text] [Related]
16. Evidence of the presence of amyloid substance in the blood of familial amyloidotic polyneuropathy patients with ATTR Val30Met mutation. Liu J; Lan J; Zhao P; Zheng F; Song J; Zhang P; Sun X Int J Clin Exp Pathol; 2014; 7(11):7795-800. PubMed ID: 25550818 [TBL] [Abstract][Full Text] [Related]
17. Distinct characteristics of amyloid deposits in early- and late-onset transthyretin Val30Met familial amyloid polyneuropathy. Koike H; Ando Y; Ueda M; Kawagashira Y; Iijima M; Fujitake J; Hayashi M; Yamamoto M; Mukai E; Nakamura T; Katsuno M; Hattori N; Sobue G J Neurol Sci; 2009 Dec; 287(1-2):178-84. PubMed ID: 19709674 [TBL] [Abstract][Full Text] [Related]
18. Heterogeneity of penetrance in familial amyloid polyneuropathy, ATTR Val30Met, in the Swedish population. Hellman U; Alarcon F; Lundgren HE; Suhr OB; Bonaiti-Pellié C; Planté-Bordeneuve V Amyloid; 2008 Sep; 15(3):181-6. PubMed ID: 18925456 [TBL] [Abstract][Full Text] [Related]
19. A rapid and sensitive prenatal diagnosis of familial amyloidotic polyneuropathy ATTR Val30Met by mass spectrometry. Yamashita T; Ando Y; Ueda M; Okamoto S; Misumi Y; Nakamura M; Takashi O; Uchino M Prenat Diagn; 2009 Oct; 29(10):930-3. PubMed ID: 19609897 [TBL] [Abstract][Full Text] [Related]
20. A possible role for miRNA silencing in disease phenotype variation in Swedish transthyretin V30M carriers. Olsson M; Norgren N; Obayashi K; Plante-Bordeneuve V; Suhr OB; Cederquist K; Jonasson J BMC Med Genet; 2010 Sep; 11():130. PubMed ID: 20840742 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]